GHLLMQLARJYDPL-UHFFFAOYSA-N
C38H31F5N12O2 — CID 154975214
Data last refreshed: (MolForge compound catalog, from PubChem)
About GHLLMQLARJYDPL-UHFFFAOYSA-N
GHLLMQLARJYDPL-UHFFFAOYSA-N (PubChem CID 154975214) has the molecular formula C38H31F5N12O2 and a molecular weight of 782.74 g/mol. Its IUPAC name is 4-N-[4-(difluoromethoxy)phenyl]-2-(2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;2-(2-methylbenzimidazol-1-yl)-4-N-[4-(trifluoromethoxy)phenyl]pyrimidine-4,6-diamine.
Molecular Properties
| Compound Name | GHLLMQLARJYDPL-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 154975214 |
| Molecular Formula | C38H31F5N12O2 |
| Molecular Weight | 782.74 g/mol |
| Exact Mass | 782.26 |
| IUPAC Name | 4-N-[4-(difluoromethoxy)phenyl]-2-(2-methylbenzimidazol-1-yl)pyrimidine-4,6-diamine;2-(2-methylbenzimidazol-1-yl)-4-N-[4-(trifluoromethoxy)phenyl]pyrimidine-4,6-diamine |
| SMILES | Cc1nc2ccccc2n1-c1nc(N)cc(Nc2ccc(OC(F)(F)F)cc2)n1.Cc1nc2ccccc2n1-c1nc(N)cc(Nc2ccc(OC(F)F)cc2)n1 |
| InChI | InChI=1S/C19H15F3N6O.C19H16F2N6O/c1-11-24-14-4-2-3-5-15(14)28(11)18-26-16(23)10-17(27-18)25-12-6-8-13(9-7-12)29-19(20,21)22;1-11-23-14-4-2-3-5-15(14)27(11)19-25-16(22)10-17(26-19)24-12-6-8-13(9-7-12)28-18(20)21/h2-10H,1H3,(H3,23,25,26,27);2-10,18H,1H3,(H3,22,24,25,26) |
| InChIKey | GHLLMQLARJYDPL-UHFFFAOYSA-N |
| XLogP | 8.40 |
| TPSA | 181.76 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 782.74 |
| LogP ≤ 5 | 8.40 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154975214 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.